These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 7545499

  • 1. Antigen-specific immunodeficiency and its relation to the spectrum of American cutaneous leishmaniasis.
    Convit J, Ulrich M.
    Biol Res; 1993; 26(1-2):159-66. PubMed ID: 7545499
    [Abstract] [Full Text] [Related]

  • 2. [Immunopathology of American tegumentary leishmaniasis].
    Castés M, Tapia FJ.
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [Abstract] [Full Text] [Related]

  • 3. The clinical and immunological spectrum of American cutaneous leishmaniasis.
    Convit J, Ulrich M, Fernández CT, Tapia FJ, Cáceres-Dittmar G, Castés M, Rondón AJ.
    Trans R Soc Trop Med Hyg; 1993; 87(4):444-8. PubMed ID: 8249076
    [Abstract] [Full Text] [Related]

  • 4. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG, Oliveira MP, Da-Cruz AM, De Luca PM, Mendonça SC, Bertho AL, Soong L, McMahon-Pratt D.
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [Abstract] [Full Text] [Related]

  • 5. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS, Azeredo-Coutinho RB, Schubach A, Conceição-Silva F, Baptista C, Moreira JS, Mendonça SC.
    Clin Infect Dis; 2005 Jan 15; 40(2):e5-12. PubMed ID: 15655736
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis.
    Castes M, Trujillo D, Rojas ME, Fernandez CT, Araya L, Cabrera M, Blackwell J, Convit J.
    Biol Res; 1993 Jan 15; 26(1-2):233-8. PubMed ID: 7670536
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.
    Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.
    Castés M, Agnelli A, Rondón AJ.
    Clin Exp Immunol; 1984 Aug 22; 57(2):279-86. PubMed ID: 6467674
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients.
    Cabrera M, Blackwell JM, Castes M, Trujillo D, Convit J, Shaw MA.
    Parasite Immunol; 2000 Feb 22; 22(2):73-9. PubMed ID: 10652119
    [Abstract] [Full Text] [Related]

  • 12. In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testing.
    Akuffo H, Darce M, Maasho K, Berhan TY.
    Am J Trop Med Hyg; 1995 Jul 22; 53(1):16-22. PubMed ID: 7625529
    [Abstract] [Full Text] [Related]

  • 13. Immunologic responsiveness in American cutaneous leishmaniasis lesions.
    Pirmez C, Cooper C, Paes-Oliveira M, Schubach A, Torigian VK, Modlin RL.
    J Immunol; 1990 Nov 01; 145(9):3100-4. PubMed ID: 1976709
    [Abstract] [Full Text] [Related]

  • 14. Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis.
    Petersen EA, Neva FA, Oster CN, Bogaert Diaz H.
    N Engl J Med; 1982 Feb 18; 306(7):387-92. PubMed ID: 6460184
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR, Filho DC, Argiro L, Dessein H, Prata A, Dessein A, Rodrigues V.
    Hum Immunol; 2009 Jun 18; 70(6):383-90. PubMed ID: 19480861
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression.
    Akuffo HO, Fehniger TE, Britton S.
    J Immunol; 1988 Oct 01; 141(7):2461-6. PubMed ID: 3171177
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.